Peptide therapeutics are emerging as a powerful class of medicines, offering high specificity, strong efficacy, and improved safety profiles compared to traditional small-molecule drugs. These therapies are composed of short chains of amino acids that mimic natural biological processes, allowing them to interact precisely with target receptors in the body. As a result, peptide therapeutics are gaining attention across various medical fields, including oncology, metabolic disorders, cardiovascular diseases, and infectious diseases.
One of the key advantages of peptide therapeutics is their ability to provide targeted treatment with minimal off-target effects. Unlike conventional drugs, peptides can be designed to bind selectively to specific receptors, reducing the risk of unwanted side effects. This precision makes them particularly useful in treating complex conditions where accuracy is critical, such as cancer and autoimmune diseases. Additionally, peptides are generally well-tolerated and biodegradable, which enhances their safety and reduces long-term toxicity concerns.
Recent advancements in biotechnology…
